Inflammatory Breast Cancer International Consortium | IBC-IC HomepageInflammatory Breast Cancer International Consortium | IBC-IC

Marwa Manai, PhD

Researcher

Title(s)

Post-doctoral Fellow (Breast Oncology), MD Anderson Cancer Center

Location(s)

  • Department of Breast Medical Oncology
  • The University of Texas MD Anderson Cancer Center
  • 1515 Holcombe Boulevard, Unit 1354
  • Houston, TX, 77030
  • United States of America

Research and Clinical Interests

IBC-Focused Research

I am a scientist-researcher working on Inflammatory Breast Cancer (IBC). I participate in different activities in oncology, including a biomarker study, epidemiological study, microenvironment and pharmaco-oncological study in IBC on xenografted animal models.

I have worked for many years to create an IBC database of Tunisian and French populations. Also, I have created a large database of breast cancer among young women in Tunisia for the national data and tumor banks in Tunisia.

I am considered a principal investigator of Inflammatory Breast Cancer research projects in Mediterranean countries; and I am participating to characterize a novel potential biomarker in IBC, which could explain the aggressiveness of IBC.

Research Interests

  • Breast Cancer
  • Epidemiology
  • Inflammatory Breast Cancer
  • Male Breast Cancer
  • Molecular Biology
  • Ovarian Cancer
  • Pharmaco-oncology Studies

Education and Board Certifications

PHD

Paoli-Calmettes Institute, CRCM-INSERM, Aix Marseille University, France (2016)

UNIVERSITY CERTIFICATES

Leadership and Management on Health, University of Washington (E-learning) and University of Tunis El Manar (2019)
Biostatistics and Basic Methodologies for Research in Biology and Medicine, Faculty of Medicine Timone, Aix Marseille University, France (2018)
Breast Disease, Faculty of Medicine of Tunis, University of Tunis El Manar (2018)

POST-DOCTORAL FELLOWSHIPS

Pasteur Institute of Tunis (2018-2019)
Faculty of Medicine of Tunis, University of Tunis El Manar (2018-2019)
Paoli-Calmettes Institute, CRCM-INSERM, Aix-Marseille University, France (2017-2019)
Salah Azaiez Institute, Tunis, Tunisia (2017-2019)

YEARS IN PRACTICE

8

Affiliations and Memberships

Principal researcher of the MOBIDOC Postdoc code 373, project entitled “Contribution to improving the prognosis and treatment of inflammatory breast cancer”

Member and Principal Investigator, PHC-Utique-CMCU code 15G0805 project of cooperation entitled "Characterization of molecular genomic and post-genomic alterations in inflammatory breast cancers"

Member, Association de Formation et de Sensibilisation à l’Oncologie Multidisciplinaire de l'Ariana (AFSOMA)

Recent Publications

Overexpression of Annexin A1 Is an Independent Predictor of Longer Overall Survival in Epithelial Ovarian Cancer
In Vivo; 2020

MARCKS protein overexpression is associated with poor prognosis in male breast cancer
Cancer Biomark, 2019

Inflammatory breast cancer in Tunisian patients: Retrospective study on epidemiological, anatomo-clinical features and therapeutic results about 210 patients
Molecular and Clinical Oncology; 2018

Stromal expression of MARCKS protein in ovarian carcinomas has unfavorable prognostic value
International Journal of Molecular Sciences; 2017

MARCKS protein overexpression in inflammatory breast cancer
Oncotarget; 2016

Candidate luminal B breast cancer genes identified by genome, gene expression and DNA methylation profiling
PLOS ONE; 2014

Affiliated IBC-IC Center(s)

  • The University of Texas MD Anderson Cancer Center
  • Houston, TX, 77030
  • Research + Treatment Center

Join IBC-IC

Become part of our international consortium of researchers, clinicians, advocates and centers worldwide dedicated to ending IBC.

IBCIC.org makes every effort to keep researcher information as up-to-date as possible.
Contact this researcher to confirm any information regarding his or her profile.